Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cholesterol-Lowering Claim Disease Status Protested By McNeil

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare opposes FDA's classification of certain cholesterol-lowering claims as disease claims in the final rule on dietary supplement structure/function claims. In a Feb. 7 citizen petition, McNeil asks the agency to reconsider its decision.

You may also be interested in...



Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Related Content

Topics

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel